Zeps N - Search Results

1

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer.

Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N, Iacopetta B. Elsaleh H, et al. Among authors: zeps n. Lancet. 2000 May 20;355(9217):1745-50. doi: 10.1016/S0140-6736(00)02261-3. Lancet. 2000. PMID: 10832824

2

Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy.

Collura A, Lagrange A, Svrcek M, Marisa L, Buhard O, Guilloux A, Wanherdrick K, Dorard C, Taieb A, Saget A, Loh M, Soong R, Zeps N, Platell C, Mews A, Iacopetta B, De Thonel A, Seigneuric R, Marcion G, Chapusot C, Lepage C, Bouvier AM, Gaub MP, Milano G, Selves J, Senet P, Delarue P, Arzouk H, Lacoste C, Coquelle A, Bengrine-Lefèvre L, Tournigand C, Lefèvre JH, Parc Y, Biard DS, Fléjou JF, Garrido C, Duval A. Collura A, et al. Among authors: zeps n. Gastroenterology. 2014 Feb;146(2):401-11.e1. doi: 10.1053/j.gastro.2013.10.054. Gastroenterology. 2014. PMID: 24512910

3

SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer.

Chew A, Salama P, Robbshaw A, Klopcic B, Zeps N, Platell C, Lawrance IC. Chew A, et al. Among authors: zeps n. PLoS One. 2011;6(7):e22047. doi: 10.1371/journal.pone.0022047. Epub 2011 Jul 26. PLoS One. 2011. PMID: 21818290 Free PMC article.

4

The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome.

Soong R, Shah N, Peh BK, Chong PY, Ng SS, Zeps N, Joseph D, Salto-Tellez M, Iacopetta B, Ito Y. Soong R, et al. Among authors: zeps n. Br J Cancer. 2009 Mar 10;100(5):676-9. doi: 10.1038/sj.bjc.6604899. Epub 2009 Feb 17. Br J Cancer. 2009. PMID: 19223906 Free PMC article.

5

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy.

Soong R, Shah N, Salto-Tellez M, Tai BC, Soo RA, Han HC, Ng SS, Tan WL, Zeps N, Joseph D, Diasio RB, Iacopetta B. Soong R, et al. Among authors: zeps n. Ann Oncol. 2008 May;19(5):915-9. doi: 10.1093/annonc/mdm599. Epub 2008 Feb 1. Ann Oncol. 2008. PMID: 18245778 Free PMC article.

6

Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer.

McCoy MJ, Hemmings C, Miller TJ, Austin SJ, Bulsara MK, Zeps N, Nowak AK, Lake RA, Platell CF. McCoy MJ, et al. Among authors: zeps n. Br J Cancer. 2015 Dec 22;113(12):1677-86. doi: 10.1038/bjc.2015.427. Epub 2015 Dec 8. Br J Cancer. 2015. PMID: 26645238 Free PMC article.

7

Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients.

Candy PA, Phillips MR, Redfern AD, Colley SM, Davidson JA, Stuart LM, Wood BA, Zeps N, Leedman PJ. Candy PA, et al. Among authors: zeps n. Br J Cancer. 2013 Aug 20;109(4):1023-30. doi: 10.1038/bjc.2013.431. Epub 2013 Jul 30. Br J Cancer. 2013. PMID: 23900217 Free PMC article.

8

Waiver of individual patient consent in research: when do potential benefits to the community outweigh private rights?

Zeps N, Iacopetta BJ, Schofield L, George JM, Goldblatt J. Zeps N, et al. Med J Aust. 2007 Jan 15;186(2):88-90. doi: 10.5694/j.1326-5377.2007.tb00808.x. Med J Aust. 2007. PMID: 17223771

9

Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response.

McCoy MJ, Hemmings C, Anyaegbu CC, Austin SJ, Lee-Pullen TF, Miller TJ, Bulsara MK, Zeps N, Nowak AK, Lake RA, Platell CF. McCoy MJ, et al. Among authors: zeps n. Oncotarget. 2017 Mar 21;8(12):19803-19813. doi: 10.18632/oncotarget.15048. Oncotarget. 2017. PMID: 28177891 Free PMC article.

10

Expression of secreted frizzled-related protein 4 (SFRP4) in primary serous ovarian tumours.

Drake J, Shearwood AM, White J, Friis R, Zeps N, Charles A, Dharmarajan A. Drake J, et al. Among authors: zeps n. Eur J Gynaecol Oncol. 2009;30(2):133-41. Eur J Gynaecol Oncol. 2009. PMID: 19480240

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results